Corrigendum to “Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer” [Crit. Rev. Oncol./Hematol. 73 (2010) 23–30]

Article Outline

• Copyright

The publisher and author regret that some errors were printed in the above paper as follows:

In Table 2, in the column “ORR, %”, the final two numbers are incorrect. These numbers should be replaced by “NR”.

In Fig. 2, the treatment schedule for Paclitaxel/Carboplatin should read “Q 21 d” not “Q 28 d”.